PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 4 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $331,000 | -61.9% | 87,041 | -48.9% | 0.00% | 0.0% |
| Q4 2019 | $868,000 | -54.3% | 170,480 | -58.3% | 0.00% | -50.0% |
| Q1 2019 | $1,899,000 | +17.1% | 409,199 | +6.0% | 0.01% | 0.0% |
| Q4 2018 | $1,622,000 | +1128.8% | 386,179 | +2103.6% | 0.01% | +500.0% |
| Q4 2014 | $132,000 | +7.3% | 17,525 | -24.2% | 0.00% | 0.0% |
| Q4 2013 | $123,000 | -15.2% | 23,109 | -29.2% | 0.00% | 0.0% |
| Q2 2013 | $145,000 | – | 32,629 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 8,951,169 | $54,871,000 | 3.38% |
| Virtus ETF Advisers LLC | 103,807 | $636,000 | 1.75% |
| BKS ADVISORS, LLC | 291,150 | $1,785,000 | 0.92% |
| Piermont Capital Management Inc. | 363,549 | $2,229,000 | 0.71% |
| TUDOR INVESTMENT CORP ET AL | 2,370,760 | $14,532,000 | 0.41% |
| SEARLE & CO. | 60,000 | $349,000 | 0.34% |
| TURNER INVESTMENTS LLC | 252,785 | $1,550,000 | 0.32% |
| RICE HALL JAMES & ASSOCIATES, LLC | 891,672 | $5,466,000 | 0.31% |
| Phocas Financial Corp. | 635,333 | $3,895,000 | 0.30% |
| TFS CAPITAL LLC | 398,283 | $2,441,000 | 0.26% |